What is it about?
This article is a critical review of studies on the evaluation of the trafficking and effector function of bone marrow-derived fibrocytes in asthma. It focuses on the clinical relevance and therapeutic implications of these investigations.
Featured Image
Why is it important?
The article highlights important methodological issues and provides solutions at the analytical and clinical levels, which may allow the use of blood fibrocytes count as a biomarker of asthma control and therapeutic responsiveness. It propose a novel therapeutic approach to block persistent fibrocytosis in difficult-to-treat asthma.
Read the Original
This page is a summary of: Involvement of fibrocytes in asthma and clinical implications, Clinical & Experimental Allergy, September 2015, Wiley,
DOI: 10.1111/cea.12525.
You can read the full text:
Contributors
The following have contributed to this page